PIK3C2A and ductal breast carcinoma in situ: A subset of mutations found to be subclonal in the DCIS became dominant in the IDC‐NST, including a PIK3C2A missense mutation, suggesting that a minor subclone of the DCIS became the dominant clone in the progression from DCIS to invasive breast cancer (Figure 3B,C).